No Data
No Data
Oppenheimer Downgrades Aerovate(AVTE.US) to Hold Rating, Cuts Target Price to $3
Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK)
Aerovate | 10-Q: Q2 2024 Earnings Report
Express News | Aerovate Therapeutics Shares Are Trading Higher After the Company Announced It Is Exploring Strategic Alternatives
Express News | Aerovate Therapeutics To Explore Strategic Alternatives Which May Include But Are Not Limited To, An Acquisition, Merger, Reverse Merger, Business Combination, Liquidation Or Other Transaction
Express News | Aerovate Therapeutics - Wedbush Pacgrow Engaged as Exclusive Advisor
103635195 : Short is coming